Background: It is not known to what extent the WHO classification scheme for MDS has been adopted in clinical practice.
Methods: We reviewed the medical records of 200 newly diagnosed MDS patients enrolled in our national registry during the years 2006-2008 to determine the scheme used.
Results: Clear WHO subtypes were recorded for 45.0% of patients, compared to 5.5% for FAB subtypes; 28.0% had MDS documented but without WHO or FAB subtype, and for 22.5%, the schema was unclear.
Conclusion: Although many MDS patients do not have a subtype or schema documented, when they do, the WHO system is widely used.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.leukres.2009.12.012 | DOI Listing |
Publication Analysis
Top Keywords
national registry
8
mds patients
8
classification myelodysplastic
4
myelodysplastic syndrome
4
syndrome national
4
registry diagnosed
4
patients
4
diagnosed patients
4
patients background
4
background extent
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!